Wockhardt informs about credit rating

29 Aug 2019 Evaluate

Wockhardt has informed that India Ratings and Research (India Ratings) has revised the Company’s ratings for short-term Bank facilities/ Commercial Paper to IND A4+ from IND A3; and for long-term loan facilities rating to IND BB+/ Negative from IND BBB-/Negative. Further informed that India Ratings have revised the rating of the Company owing to refinancing risks, R&D expenses, regulatory overhang etc. The detailed Press Release of India Ratings is also enclosed .

The above information is a part of company’s filings submitted to BSE.

Wockhardt Share Price

230.55 5.55 (2.47%)
08-Dec-2022 18:01 View Price Chart
Company Name CMP
Sun Pharma Inds. 980.95
Cipla 1107.15
Dr. Reddys Lab 4355.35
Lupin 754.55
Zydus Lifesciences 411.45
View more..